2012
Unraveling the autoimmune translational research process layer by layer
Blumberg RS, Dittel B, Hafler D, von Herrath M, Nestle FO. Unraveling the autoimmune translational research process layer by layer. Nature Medicine 2012, 18: 35-41. PMID: 22227670, PMCID: PMC4592149, DOI: 10.1038/nm.2632.Peer-Reviewed Original Research
1996
Antigen-specific therapies for the treatment of autoimmune diseases
Hafler D, Weiner H. Antigen-specific therapies for the treatment of autoimmune diseases. 1996, 61-76. DOI: 10.1007/978-3-642-61191-9_6.Peer-Reviewed Original ResearchAntigen-specific therapyInfectious agentsMajor histocompatibility complexAutoimmune disordersAutoimmune diseasesT cellsLocal antigen-presenting cellsOrgan-specific autoimmune diseasesHuman autoimmune disordersAntigen-presenting cellsOrgan-specific proteinsRange of antigensAutoimmune processAutoimmune cascadeHistocompatibility complexDisordersTherapyDiseasePrimary targetCellsVirusOrgansAgentsSuperantigensEtiology
1992
Treatment of Multiple Sclerosis with Cyclophosphamide
Mackin G, Dawson D, Hafler D, Weiner H. Treatment of Multiple Sclerosis with Cyclophosphamide. Clinical Medicine And The Nervous System 1992, 199-216. DOI: 10.1007/978-1-4471-3184-7_9.Peer-Reviewed Original Research